Iloprost (ILO) in systemic sclerosis (SSC): The safety experience of two Italian centres

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2016
This article has no abstract
Epistemonikos ID: 67653033874753bf9c0aba91ddb9a1272c8b7db3
First added on: Feb 07, 2025